BUPIVAXINE is a local anesthetic agent of the amide type. Bupivacaine in Dextrose produces a moderate muscular relaxation of the lower extremities lasting 2-2.5 hours. The motor blockade of the abdominal muscles makes the solution suitable for performing abdominal surgery lasting 45-60 minutes. It is indicated as intrathecal spinal anesthesia in adults and children of all ages.
BUPIVAXINE was launched in December 2021 and is 41% more affordable than the leading brand.
BUPIVAXINE is manufactured by Jayson Pharmaceuticals, an ISO (9001:2015) certified and one of the leading pharmaceutical companies in Bangladesh.
DISCLAIMER: The following contents are intended for healthcare professionals only. If you are a patient or general mass viewing this site, we advise you to clarify with your doctor any information you read herein.
|
Generic Name:
|
Bupivacaine in Dextrose
|
|
Brand Name:
|
Bupivaxine
|
|
Sizes:
|
5 mg/80 mg
|
|
Preparation:
|
5 mg/80 mg per ml ampoule; DOSAGE FORM: Solution for Injection (Spinal)
|
|
Name of Manufacturer
|
Jayson Pharmaceuticals, Ltd.
|
|
Place of Manufacturer:
|
Bangladesh
|
|
Shelf Life
|
24 months
|
|
Storage Condition:
|
Store at temperature not exceeding 30 ͦC
|
|
Packaging:
|
In Alu/PVC tray containing 2 glass ampoules x 4 mL (Box of 10s)
|
|
FDA Registration:
|
DRP-8106-03
|
